Atlas Trials

Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Clinical trial NCT07137793 · RECRUITING

Trial details

NCT number
NCT07137793
Sponsor
Tanta University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Doxorubicin Induced CardiotoxicityBreast Cancer
Start date
2025-05-25
Primary completion
2026-05-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.